Mechanism underlying an elevated serum bile acid level in chronic renal failure patients

International Urology and Nephrology

Volumn 47, Issue 2, 2015, Pages 345-351

  Chu, Lei ^a,b   Zhang, Kangkang ^b   Zhang, Yingying ^b   Jin, Xunbo ^a   Jiang, Huaxin ^b  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b Tengzhou Central People s Hospital   (China)

Author keywords

Bile acid; Chronic renal failure; Glomerular filtration rate; Kidney; Puncture biopsy

Indexed keywords

APICAL SODIUM DEPENDENT BILE SALT TRANSPORTER; BILE ACID; CARRIER PROTEINS AND BINDING PROTEINS; EOSIN; HEMATOXYLIN; MESSENGER RNA; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 2; ORGANIC SOLUTE TRANSPORTER ALPHA; ORGANIC SOLUTE TRANSPORTER BETA; UNCLASSIFIED DRUG; CARRIER PROTEIN; COTRANSPORTER; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2; ORGANIC ANION TRANSPORTER; ORGANIC SOLUTE TRANSPORTER ALPHA, HUMAN; ORGANIC SOLUTE TRANSPORTER BETA, HUMAN; SODIUM-BILE ACID COTRANSPORTER;

ADULT; AGED; ARTICLE; BILE ACID BLOOD LEVEL; BILE URINE LEVEL; BLOOD SAMPLING; CELL PROLIFERATION; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY FIBROSIS; KIDNEY PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MESANGIUM CELL; NEPHROSCLEROSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; URINALYSIS; URINE VOLUME; BLOOD; FIBROSIS; GENETICS; GLOMERULUS; KIDNEY PROXIMAL TUBULE; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SCLEROSIS;

ADULT; BILE ACIDS AND SALTS; CELL PROLIFERATION; ENDOTHELIAL CELLS; FEMALE; FIBROSIS; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY GLOMERULUS; KIDNEY TUBULES, PROXIMAL; MALE; MEMBRANE TRANSPORT PROTEINS; MESANGIAL CELLS; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; ORGANIC ANION TRANSPORTERS, SODIUM-DEPENDENT; RNA, MESSENGER; SCLEROSIS; SYMPORTERS;

EID: 84925491051     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-014-0901-0     Document Type: Article

References (32)

1. Javitt NB (1994) Bile acid synthesis from cholesterol: regulatory and auxiliary pathways. FASEB J 8:1308–1311
2. Vlahcevic ZR, Pandak WM, Stravitz RT (1999) Regulation of bile acid biosynthesis. Gastroenterol Clin North Am 28:1–25
3. Swann JR, Want EJ, Geier FM et al (2011) Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc Natl Acad Sci USA. doi:10.1073/pnas.1006734107
4. Chiang JY (2004) Regulation of bile acid synthesis pathways nuclear receptors and mechanisms. J Hepatol 40:539–551
5. Chiang JY (2013) Bile acid metabolism and signaling. Compr Physiol 3:1191–1212
6. Erlinger S (2014) Bile acids in cholestasis: bad for the liver, not so good for the kidney. Clin Res Hepatol Gastroenterol 38:392–394
7. Chen X, Lou G, Meng Z, Huang W (2011) TGR5: a novel target for weight maintenance and glucose metabolism. Exp Diabetes Res. doi:10.1155/2011/853501
8. Mak RH, DeFronzo RA (1992) Glucose and insulin metabolism in uremia. Nephron 61:377–382
9. Cheung AK, Wu LL, Kablitz C, Leypoldt JK (1993) Atherogenic lipids and lipoproteins in hemodialysis patients. Am J Kidney Dis 22:271–276
10. Jimenez F, Monte MJ, El-Mir MY, Pascual MJ, Marin JJ (2002) Chronic renal failure-induced changes in serum and urine bile acid profiles. Dig Dis Sci 47:2398–2406
11. Kobayashi T, Matsumura Y, Ozawa T et al (2014) Exploration of novel predictive markers in rat plasma of the early stages of chronic renal failure. Anal Bioanal Chem 406:1365–1376
12. Levey AS, Coresh J, Balk E et al (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139:137–147
13. Kong X, Yuan H, Fan J, Li Z, Wu T, Jiang L (2013) Lipid-lowering agents for nephrotic syndrome. Cochrane Database Syst Rev. doi:10.1002/14651858.CD005425
14. Shearer GC, Stevenson FT, Atkinson DN, Jones H, Staprans I, Kaysen GA (2001) Hypoalbuminemia and protein uria contribute to separately to reduced lipoprotein catabolism in the nephrotic syndrome. Kidney Int 59:179–189
15. Idorn T, Knop FK, Jørgensen MB et al (2014) Elimination and degradation of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with end-stage renal disease. J Clin Endocrinol Metab 99:2457–2466
16. Vaziri ND (2006) Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences. Am J Physiol Renal Physiol 290:F262–F272
17. Van Berge Henegouwen GP, Brandt KH, Eyssen H, Parmentier G (1976) Sulphated and unsulphated bile acids in serum, bile, and urine of patients with cholestasis. Gut 17:861–869
18. Craddock AL, Love MW, Daniel RW et al (1998) Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter. Am J Physiol 274:G157–G169
19. Schaub TP, Kartenbeck J, Konig J et al (1999) Expression of the MRP2 gene-encoded conjugate export pump in human kidney proximal tubules and in renal cell carcinoma. J Am Soc Nephrol 10:1159–1169
20. Soroka CJ, Ballatori N, Boyer JL (2010) Organic solute transporter, OSTalpha–OSTbeta: its role in bile acid transport and cholestasis. Semin Liver Dis 30(2):178–185
21. Naicker T, Randeree IG, Moodley J, Khedun SM, Ramsaroop R, Seedat YK (1997) Correlation between histological changes and loss of anionic charge of the glomerular basement membrane in early-onset pre-eclampsia. Nephron 75:201–207
22. Pannarale G, Carbone R, Del Mastro G et al (2010) The aging kidney: structural changes. J Nephrol 23:S37–S40
23. Balestri PL, Berni R, Cupisti A, Giordani R (1995) An increase in bile acids in the serum of patients with chronic kidney failure. Minerva Med 86:207–209
24. Yamaga N, Adachi K, Kohara H, Shimizu K (1988) Bile acids of patients with renal failure (possibility of bile acid secretion in the distal tubule). Biochem Biophys Res Commun 152:197–202
25. Dashti N, Einollahi N, Nabatchian F, Moradi Sarabi M, Zarebavani M (2012) Significance of albumin and C-reactive protein variations in 300 end stage renal disease patients in Tehran University of Medical Sciences Hospitals during year 2010. Acta Med Iran 50:197–202
26. Rutkowski B, Tylicki L, Manitius J, Lysiak-Szydlowska W (1999) Hypertensive nephropathy: an increasing clinical problem. Miner Electrolyte Metab 25:65–68
27. Wolf KK, Brouwer KR, Pollack GM, Brouwer KL (2008) Effect of albumin on the biliary clearance of compounds in sandwich-cultured rat hepatocytes. Drug Metab Dispos 36:2086–2092
28. Dumaswala R, Berkowitz D, Heubi JE (1996) Adaptive response of the enterohepatic circulation of bile acids to extrahepatic cholestasis. Hepatology 23:623–629
29. Lillienau J, Crombie DL, Munoz J, Longmire-Cook SJ, Hagey LR, Hofmann AF (1993) Negative feedback regulation of the ileal bile acid transport system in rodents. Gastroenterology 104:38–46
30. Gai Z, Chu L, Hiller C et al (2014) Effect of chronic renal failure on the hepatic, intestinal and renal expression of bile acid transporters. Am J Physiol Renal Physiol 306:F130–F137
31. Pandak WM, Vlahcevic ZR, Heuman DM, Kreig RJ, Hanna JD, Chan JC (1994) Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and cholesterol 7 alphahydroxylase in rats with subtotal nephrectomy. Kidney Int 46:358–364
32. Liang K, Vaziri ND (1997) Gene expression of LDL receptor, HMG-CoA reductase, and cholesterol-7a-hydroxylase in chronic renal failure. Nephrol Dial Transplant 12:1381–1386